Imagi International Holdings (FRA:BOI7) Research & Development: €0.00 Mil (TTM As of Dec. 2025)


FRA:BOI7 Imagi International Holdings Ltd FRA:BOI7
33 GF Score
Price €0.77
GF Value €0.02
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Imagi International Holdings Research & Development?

Imagi International Holdings FRA:BOI7 -18.18% 33 Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus rates FRA:BOI7 with a GF Score™ of 33/100 and a GF Value™ of €0.02 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Imagi International Holdings's Research & Development for the six months ended in Dec. 2025 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

Imagi International Holdings  (FRA:BOI7) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Imagi International Holdings Research & Development Related Terms

Imagi International Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Imagi International Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imagi International Holdings Research & Development Chart

Imagi International Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Imagi International Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:BOI7
33GF Score
Imagi International Holdings Ltd FRA:BOI7
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Imagi International Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Imagi International Holdings (FRA:BOI7) has a Research & Development of €0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Imagi International Holdings and its competitors.
Is Imagi International Holdings' Research & Development too high?
Imagi International Holdings' current Research & Development is €0.00 Mil. Overall, Imagi International Holdings has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Imagi International Holdings' Research & Development compare to FRHC?
Imagi International Holdings' Research & Development of €0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Diversified Financial Services company?
A good Research & Development depends on the Diversified Financial Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Imagi International Holdings and its competitors. Imagi International Holdings's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imagi International Holdings stock overvalued right now?
Based on GuruFocus' analysis, Imagi International Holdings (FRA:BOI7) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.02, compared to a current price of €0.77 — trading 3725% above its estimated fair value. The current Research & Development is €0.00 Mil. Imagi International Holdings' overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Imagi International Holdings (FRA:BOI7), the current Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Imagi International Holdings (FRA:BOI7) Overvalued in 2026?

Based on GuruFocus' analysis, Imagi International Holdings stock appears to be overvalued. The current stock price of €0.77 is trading 3725% above its estimated GF Value™ of €0.02. GuruFocus considers Imagi International Holdings to be Significantly Overvalued.

Key valuation signals for FRA:BOI7:

  • Research & Development: €0.00 Mil
  • GF Value™: €0.02 vs. price of €0.77 (3725% above fair value)
  • GF Score™: 33/100 with 4 warning signs

No single metric tells the full story. See the FRA:BOI7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Imagi International Holdings Business Description

Other Exchanges 00585:Hong Kong
Address 28 Marble Road, Room 2205-09, 22nd Floor, China United Centre, North Point, Hong Kong, HKG
Imagi International Holdings Ltd is engaged in the provision of Integrated Financial Services, investment holdings, CGI business and entertainment business. The group operates two main businesses: Integrated Financial Services, and entertainment business divided into four different segments namely: Securities Brokerage and Asset Management (including securities brokerage and related financial services and margin financing services); Provision of Finance (excluding margin financing services within the brokerage business); Trading of Securities; and entertainment engages in computer graphic imaging (CGI) business and Entertainment business (including film rights investment, film distribution license rights business and entertainment event investment).
33GF Score

Get the complete analysis for FRA:BOI7

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.77
Price
€0.02
GF Value